NSAID-Exacerbated Respiratory Disease—A Century of Discovery and Innovation

Whitney W. Stevens; Joaquim Mullol

doi:10.1016/j.jaip.2024.09.011

NSAID-Exacerbated Respiratory Disease—A Century of Discovery and Innovation

Whitney W. Stevens^*, Joaquim Mullol^*

^*Corresponding author for this work

Medicine, Allergy Division

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	2945-2946
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	12
Issue number	11
DOIs	https://doi.org/10.1016/j.jaip.2024.09.011
State	Published - Nov 2024

Funding

Conflicts of interest: W. W. Stevens has served on advisory boards for Regeneron, GlaxoSmithKline, and Melinta Therapeutics, and her work was supported by the National Institute of Allergy and Infectious Diseases (grant nos. K23AI141694 and P01AI145818 [CRISP2]) and the Walder Foundation/DDCF. J. Mullol has served in a speakers\u2019 bureau or advisory board or received a research grant/clinical trials from Almirall, AstraZeneca, GlaxoSmithKline, Glenmark, Lilly, Menarini, Mitsubishi-Tanabe, MSD, Noucor/Uriach Group, Novartis, Optinose, Procter & Gamble, Regeneron Pharmaceuticals, Inc, Sanofi-Genzyme, and Viatris/MEDA Pharma.

ASJC Scopus subject areas

Immunology and Allergy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaip.2024.09.011

Cite this

@article{bb7e6b2244e74f01848713111119a1cf,

title = "NSAID-Exacerbated Respiratory Disease—A Century of Discovery and Innovation",

author = "Stevens, {Whitney W.} and Joaquim Mullol",

year = "2024",

month = nov,

doi = "10.1016/j.jaip.2024.09.011",

language = "English (US)",

volume = "12",

pages = "2945--2946",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "11",

}

TY - JOUR

T1 - NSAID-Exacerbated Respiratory Disease—A Century of Discovery and Innovation

AU - Stevens, Whitney W.

AU - Mullol, Joaquim

PY - 2024/11

Y1 - 2024/11

UR - http://www.scopus.com/inward/record.url?scp=85207945416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85207945416&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2024.09.011

DO - 10.1016/j.jaip.2024.09.011

M3 - Editorial

C2 - 39515972

AN - SCOPUS:85207945416

SN - 2213-2198

VL - 12

SP - 2945

EP - 2946

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 11

ER -

NSAID-Exacerbated Respiratory Disease—A Century of Discovery and Innovation

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this